Skip to main content

Author: Customer Service

FDA accepts supplemental Biologics License Application for Roche’s Lunsumio and Polivy combination for people with relapsed or refractory large B-cell lymphoma

Filing acceptance based on data from the phase III SUNMO study where subcutaneous Lunsumio VELO plus Polivy demonstrated a 59% reduction in risk of disease progression or death1 People with relapsed or refractory LBCL represent one of the highest unmet need populations in lymphoma and require timely access to effective therapies If approved, this outpatient-ready regimen could enable access to care in the community setting, where most US patients receive treatmentBasel, June 18, 2026 – Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) for Lunsumio VELO™ (mosunetuzumab), as a subcutaneous formulation, in combination with Polivy® (polatuzumab vedotin) for the treatment of adult patients with relapsed...

Continue reading

TGS Announces Pelotas Sul Phase 1 Multi-client Survey Offshore Brazil

OSLO, Norway (18 June 2026) – TGS, a global provider of energy data and intelligence, in joint venture¹ with SLB, announce the Pelotas Sul Phase 1 multi-client 3D seismic survey in the Pelotas Basin offshore southern Brazil. The survey covers approximately 13,500 square kilometers. The Ramform Tethys mobilized for the survey in December 2025, with data acquisition expected to be completed in early Q3 2026. The project marks a significant step in expanding TGS’ high‑quality seismic coverage across one of Brazil’s most promising frontier regions. The Pelotas Basin has seen growing interest in recent years, supported by extensive geologic analogs, including successful exploration results along the conjugate margin. The area features a diverse range of play concepts, including turbidite systems, deep‑water channels, and stratigraphic...

Continue reading

SkiStar AB Interim Report September 2025-May 2026

STABLE DEVELOPMENT IN UNCERTAIN TIMES Third QuarterNet sales amounted to SEK 1,441 million (1,375), an increase of SEK 66 million, 5 percent. Operating profit amounted to SEK 347 million (377), a decrease of SEK 30 million, 8 percent. Operating profit adjusted for capital gains from exploitation assets amounted to SEK 346 million (347), a decrease of SEK 1 million, 0 percent. Capital gains from exploitation assets were included with SEK 1 million (30). Cash flow from operating activities amounted to SEK -368 million (-460), an increase of SEK 92 million. Basic and diluted earnings per share amounted to SEK 3.43 (3.82), a decrease of 10 percent.First Nine MonthsNet sales amounted to SEK 4,663 million (4,348), an increase of SEK 315 million, 7 percent. Operating profit amounted to SEK 1,146 million (1,095), an increase of SEK 51 million,...

Continue reading

Nestlé appoints Antonia Wanner as Chief Communications and Sustainability Officer

[Ad hoc announcement pursuant to Art. 53 LR] This press release is also available in Français (pdf) and Deutsch (pdf) ………….Nestlé appoints Antonia Wanner as Chief Communications and Sustainability OfficerNestlé’s Board of Directors has appointed Antonia Wanner, currently Chief Sustainability Officer, as Chief Communications and Sustainability Officer and a member of the Group Executive Board, effective 1 September 2026. Antonia Wanner joined Nestlé in Germany in 1996 as an in-house lawyer and has since held senior leadership positions in Procurement, Sales and Sustainability. Philipp Navratil, CEO of Nestlé, commented: “Antonia will make Corporate Communications an even stronger driver of business impact, closely aligned with our strategic priorities and focused on disciplined execution. Bringing Corporate...

Continue reading

Diversified Royalty Corp. Announces Results of Annual General and Special Meeting

VANCOUVER, British Columbia, June 17, 2026 (GLOBE NEWSWIRE) — Diversified Royalty Corp. (TSX: DIV, DIV.DB.A and DIV.DB.B) (the “Corporation” or “DIV”) is pleased to announce that at its annual general and special meeting of shareholders held on June 17, 2026 (the “Meeting”), all directors nominated as listed in DIV’s information circular dated May 7, 2026 were elected for the ensuing year. As a ballot was not required, the number of votes disclosed in the below table reflects only the proxies received by management of DIV in advance of the Meeting:Director Votes For   Votes WithheldNumber Percentage   Number PercentagePaula Rogers 41,015,296 92.40%   3,373,274 7.60%Roger Chouinard 38,944,894 87.74%   5,443,676 12.26%Johnny Ciampi 41,048,300 92.47%   3,340,270 7.53%Garry Herdler 41,060,823 92.50%   3,327,747 7.50%Sherry...

Continue reading

Legend Biotech Corporation Announces Pricing of Public Offering

BRIDGEWATER, N.J., June 17, 2026 (GLOBE NEWSWIRE) — Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech” or the “Company”), a global leader in cell therapy, today announced the pricing of an underwritten public offering of 7,700,000 American Depositary Shares (“ADSs”), each representing two ordinary shares of the Company, at a public offering price of $29.35 per ADS. In addition, Legend Biotech has granted the underwriters a 30-day option to purchase up to an additional 1,155,000 ADSs at the public offering price, less underwriting discounts and commissions. All of the ADSs are being offered by Legend Biotech. The gross proceeds to Legend Biotech from the offering, before deducting underwriting discounts and commissions and estimated offering expenses payable by Legend Biotech, are expected to be approximately $226 million,...

Continue reading

Yorkville International Capital Corp. Announces Closing of $230,000,000 Initial Public Offering

MOUNTAINSIDE, N.J., June 17, 2026 (GLOBE NEWSWIRE) — Yorkville International Capital Corp. (the “Company”) announced today that it closed its initial public offering of 23,000,000 units, including the issuance of 3,000,000 units as result of the underwriters’ exercise of their over-allotment option in full, at $10.00 per unit. The gross proceeds from the offering were $230 million before deducting underwriting discounts and estimated offering expenses. The units began trading on the Global Market tier of The Nasdaq Stock Market (“Nasdaq”) under the ticker symbol “YICCU” on June 16, 2026. Each unit consists of one Class A ordinary share and one-third of one redeemable warrant. Each whole warrant entitles the holder to purchase one Class A ordinary share of the Company at a price of $11.50 per share,...

Continue reading

MediPharm Labs Announces Voting Results from the 2026 Annual and Special Meeting of Shareholders

TORONTO, June 17, 2026 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”), a pharmaceutical company specialized in precision-based cannabinoids, today announced the results of matters voted on at its annual and special meeting (the “Meeting”) of holders of common shares (“Shareholders”) held today. There were 389 Shareholders represented virtually or by proxy at the Meeting holding an aggregate of 130,357,074 common shares, representing 30.68% of MediPharm’s total issued and outstanding common shares as of the record date for the Meeting. As the Meeting was held virtually, all resolutions were passed by way of ballot. Complete voting results for each of the matters presented at the Meeting are provided below. Board Changes Following his re-election as a...

Continue reading

Liberty Gold Reports Annual General Meeting Results and Corporate Update

VANCOUVER, British Columbia, June 17, 2026 (GLOBE NEWSWIRE) — Liberty Gold Corp. (TSX: LGD; OTCQX: LGDTF) (“Liberty Gold” or the “Company”) announces voting results from the Company’s Annual General Meeting of Shareholders held on June 17, 2026 (the “Meeting”). Mr. Rob Pease, who has served on the Board of Liberty Gold for approximately 15 years, including a period as Chair of the Board, did not stand for re-election as a director at the Meeting. Mr. Pease has played a key role in guiding the Company through multiple stages of its development and will remain engaged with Liberty Gold in an advisory capacity as Corporate Advisor, ensuring continued access to his experience and perspective. On behalf of the Board and management team, Liberty Gold extends its sincere appreciation to Mr. Pease for his longstanding service, leadership,...

Continue reading

Crown Crafts to Announce Fourth Quarter and Full Year Fiscal 2026 Results on June 24, 2026

GONZALES, La., June 17, 2026 (GLOBE NEWSWIRE) — Crown Crafts, Inc. (NASDAQ-CM: CRWS) (the “Company”), a producer, designer, and distributor of infant, toddler, and juvenile consumer products, today announced that it will release the results of its operations for the fourth quarter and full year fiscal 2026 before the market opens on Wednesday, June 24, 2026. Olivia W. Elliott, President and Chief Executive Officer, and Claire K. Spencer, Vice President and Chief Financial Officer, will host a teleconference at 8:00 a.m. Central Time on that day to discuss the Company’s results. Interested individuals may join the teleconference by dialing (844) 539-3703 or (412) 652-1273 and asking to join the Crown Crafts, Inc. call. The teleconference can also be accessed in listen-only mode by visiting the Company’s website at www.crowncrafts.com....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.